Researchers at Karolinska Institutet in Sweden have managed to sequence the giant genome of a salamander, the Iberian ribbed newt, which is a full six times greater than the human genome.
Amongst the early findings is a family of genes that can provide clues to the unique ability of salamanders to rebuild complex tissue, even body parts. The study is published in Nature Communications.
This is the first time that an entire newt genome has been sequenced, an achievement that can give rise to new discoveries on the amphibian’s ability to recreate brain neurons as well as entire body parts. Amongst the first findings are a multitude of copies of a certain microRNA group, which in mammals is mainly found in embryonic stem cells, but also in tumour cells.
“It will be exciting to figure out how regeneration in the adult organism re-activates embryonic genes,” says study leader Professor András Simon at Karolinska Institutet’s Department of Cell and Molecular Biology. “What’s needed now are functional studies of these microRNA molecules to understand their function in regeneration. The link to cancer cells is also very interesting, especially bearing in mind newts’ marked resistance to tumour formation.”
Even though the abundance of stem cell microRNA genes is quite surprising, it alone cannot explain how salamanders regenerate so well. Professor Simon predicts that the explanation lies in a combination of genes unique to salamanders and how other more common genes orchestrate and control the actual regeneration process.
One of the reasons why salamander genomes have not been sequenced before is its sheer size – six times bigger than the human genome in the case of the Iberian newt, which has posed an enormous technical and methodological challenge.
“It’s only now that the technology is available to handle such a large genome,” says Professor Simon. “The sequencing per se doesn’t take that long – it’s recreating the genome from the sequences that’s so time consuming.”
“We all realised how challenging it was going to be,” recounts first author Ahmed Elewa, postdoctoral fellow at the same department. “But the very fact that it was such a challenge made it all the more exciting.”
The group at Karolinska Institutet is now engaging with other researchers to discover what can be learned from the newt genome and test new hypotheses through systematic comparisons with mammals.
“We showed ten years ago that salamanders can recreate all the cells that die in Parkinson’s disease in the space of four weeks,” says Professor Simon. “We can now delve deeply into the molecular processes underlying this ability. Although we’re doing basic research, our findings can hopefully lead to the development of new regenerative strategies for humans.”
The Latest on: Regenerative medicine
- CTI Announces Contract Development and Manufacturing Initiative During Alliance for Regenerative Medicine Meeting on the Mesaon October 13, 2021 at 1:36 pm
CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announced plans today to offer contract development and manufacturing services.
- Translational Regenerative Medicine Market 2021 Share, Growth by Top Company, Region, Application, Driver, Trends and Forecasts by 2027on October 13, 2021 at 12:22 am
Final Report will add the analysis of the impact of COVID-19 on this industry.” Global “ Translational Regenerative Medicine Market ” report offers detailed analysis of the market size forecasts 2021- ...
- Lab Produced Organs Have A Promising Future Thanks To The Team At The Wake Forest Instituteon October 12, 2021 at 12:54 pm
The Wake Forest Institute for Regenerative Medicine (WFIRM), there’s a capable, coordinated team of engineers and scientists working incessantly to solve ...
- RepliCel Life Sciences Appoints One of Japan's Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisoron October 12, 2021 at 3:00 am
Kunihiko Suzuki, one of the leading pioneers in Japan's emerging regenerative medicine industry, commits to a role as Senior Strategic Advisor to RepliCel's Board of DirectorsVANCOUVER, BC / ...
- Regenerative therapy linked to QOL benefit for patients with SUIon October 11, 2021 at 12:08 pm
In this interview, Melissa R. Kaufman, MD, PhD, FACS, describes the promise of a regenerative approach to treating recurrent incontinence in women known as autologous muscle derived cells for urinary ...
- Delivering the Il-10 Gene into Human Donor Lungs in the McEwen Centre for Regenerative Medicine, UHN (IMAGE)on October 9, 2021 at 3:10 pm
Dr. Marcelo Cypel, Toronto General Hospital Surgical Lung Transplant Fellow, and Dr. Shaf Keshavjee, Senior Scientist in the McEwen Centre for Regenerative Medicine, University Health Network and ...
- What surgeons are saying about regenerative medicine in 2021on October 8, 2021 at 1:11 pm
Regenerative medicine remains a hot topic among spine and orthopedic surgeons. From stem cell treatments to bone grafts, biologic technology is growing, and many surgeons are optimistic.
- QC Kinetix (Sherman) Offers Regenerative Medicine and Non-Surgical Solutions For Damaged Tissues and Jointson October 8, 2021 at 8:33 am
Sherman, TX - QC Kinetix sets itself apart by offering patients a high degree of attention and service in a relaxing environment. The worldwide ...
- The Regenerative Medicine Institute of Nevada Has Published a New Article on the Top Ten Benefits of Peptide Therapyon October 7, 2021 at 5:44 am
The Regenerative Medicine Institute of Nevada, an advanced therapy medical spa center, has published a new article titled, "The Top ...
- ViaCyte to Present at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesaon October 7, 2021 at 5:06 am
ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, announced today that it will present at the Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa on October 14, ...
via Google News and Bing News